Literature DB >> 12021903

Cholangitis score: a scoring system to predict severe cholangitis in gallstone pancreatitis.

Masatoshi Isogai1, Akihiro Yamaguchi, Tohru Harada, Yuji Kaneoka, Masahiko Suzuki.   

Abstract

BACKGROUND/PURPOSES: Emergency biliary decompression and stone extraction are mandatory for patients with gallstone pancreatitis who have ampullary stone impaction or persistent stones and pus in the bile duct (severe cholangitis). The aim of this study was to devise a simple scoring system for the prediction of complicating severe cholangitis in gallstone pancreatitis.
METHODS: Clinical signs, laboratory data, and ultrasonography (US) findings at the time of admission, and the bile duct pathology at the time of bile duct exploration, were reviewed in 66 patients with gallstone pancreatitis. Variables which discriminated 26 patients with bile duct stones from 40 without were defined as predictive factors of bile duct stones. The receiver operating characteristic (ROC) curve was used to determine the optimal cutoff values of numerical variables. One point was allocated to each predictive factor, and the total score was defined as the cholangitis score (CS). Bile duct pathology identified at the time of bile duct exploration was graded into three categories: mild, moderate, and severe cholangitis. A threshold value of the CS, claimed to be predictive of severe cholangitis, was determined by using the ROC curve.
RESULTS: The scoring system consisted of four predictive factors: (1) pyrexia (temperature > or =38 degrees C), (2) elevated serum bilirubin (> or =2.2 mg/dl), (3) dilated bile duct (> or =11 mm maximum diameter on US), and (4) bile duct stones detected on US. The scoring system predicted severe cholangitis with 92% sensitivity and 98% specificity in patients with scores of three or four points.
CONCLUSIONS: Patients with gallstone pancreatitis who meet three or four of the above predictive factors at the time of admission are likely to have severe cholangitis, and should be rapidly treated by biliary decompression and stone extraction.

Entities:  

Mesh:

Year:  2002        PMID: 12021903     DOI: 10.1007/s005340200010

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  6 in total

1.  Preventive saline irrigation of the bile duct after the endoscopic removal of common bile duct stones.

Authors:  Sang Eon Jang; Dong-Won Ahn; Sang Hyub Lee; Ban Seok Lee; Ji Bong Jeong; Jin-Hyeok Hwang; Ji Kon Ryu; Yong-Tae Kim; Kyoung Ho Lee; Young Hoon Kim
Journal:  Dig Dis Sci       Date:  2013-04-02       Impact factor: 3.199

2.  Early endoscopic intervention versus early conservative management in patients with acute gallstone pancreatitis and biliopancreatic obstruction: a randomized clinical trial.

Authors:  Alejandro Oría; Daniel Cimmino; Carlos Ocampo; Walter Silva; Gustavo Kohan; Hugo Zandalazini; Carlos Szelagowski; Luis Chiappetta
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

3.  Outcomes of cholecystectomy after endoscopic sphincterotomy for choledocholithiasis.

Authors:  Nechol L Allen; Ruth R Leeth; Kelly R Finan; Darren S Tishler; Selwyn M Vickers; C Mel Wilcox; Mary T Hawn
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

4.  Management for CBD stone-related mild to moderate acute cholangitis: urgent versus elective ERCP.

Authors:  Sang Eon Jang; Sang Wook Park; Ban Seok Lee; Cheol Min Shin; Sang Hyub Lee; Jin-Wook Kim; Sook-Hyang Jeong; Nayoung Kim; Dong Ho Lee; Joo Kyung Park; Jin-Hyeok Hwang
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

5.  Identification of risk factors for an unfavorable laparoscopic cholecystectomy course after endoscopic retrograde cholangiography in the treatment of choledocholithiasis.

Authors:  S C Donkervoort; O van Ruler; L M Dijksman; A A van Geloven; E G Pierik
Journal:  Surg Endosc       Date:  2009-08-26       Impact factor: 4.584

Review 6.  Cholangitis: Diagnosis, Treatment and Prognosis.

Authors:  Amir Houshang Mohammad Alizadeh
Journal:  J Clin Transl Hepatol       Date:  2017-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.